600566 济川药业
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额1,338,8033,463,9592,620,8331,894,3291,781,691
投资活动产生之现金流量净额1,663,548(394,228)(1,503,306)(673,298)(1,481,147)
筹资活动产生之现金流量净额651,746(150,689)(117,582)(361,192)373,798
汇率变动对现金及现金等价物的影响----------
现金及现金等价物净增加/(减少)3,654,0972,919,042999,945859,840674,341
期初现金及现金等价物余额7,737,9834,818,9413,818,9962,959,1572,284,815
期末现金及现金等价物余额11,392,0807,737,9834,818,9413,818,9962,959,157